James R Mcnab - Net Worth and Insider Trading
James R Mcnab Net Worth
The estimated net worth of James R Mcnab is at least $41,439 dollars as of 2024-11-10. James R Mcnab is the Director of Curis Inc and owns about 9,297 shares of Curis Inc (CRIS) stock worth over $41,093. James R Mcnab is also the Director of Titan Pharmaceuticals Inc and owns about 83 shares of Titan Pharmaceuticals Inc (TTNP) stock worth over $346. Details can be seen in James R Mcnab's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R Mcnab has not made any transactions after 2018-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R Mcnab
James R Mcnab Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Mcnab owns 3 companies in total, including Titan Pharmaceuticals Inc (TTNP) , Curis Inc (CRIS) , and Echo Therapeutics Inc (ECTE) .
Click here to see the complete history of James R Mcnab’s form 4 insider trades.
Insider Ownership Summary of James R Mcnab
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TTNP | Titan Pharmaceuticals Inc | 2021-02-10 | director |
| CRIS | Curis Inc | 2017-05-05 | director |
| ECTE | Echo Therapeutics Inc | 2003-10-09 | director |
James R Mcnab Latest Holdings Summary
James R Mcnab currently owns a total of 2 stocks. Among these stocks, James R Mcnab owns 9,297 shares of Curis Inc (CRIS) as of May 5, 2017, with a value of $41,093 and a weighting of 99.16%. James R Mcnab also owns 83 shares of Titan Pharmaceuticals Inc (TTNP) as of September 21, 2018, with a value of $346 and a weighting of 0.84%.
Latest Holdings of James R Mcnab
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRIS | Curis Inc | 2017-05-05 | 9,297 | 4.42 | 41,093 |
| TTNP | Titan Pharmaceuticals Inc | 2018-09-21 | 83 | 4.17 | 346 |
Holding Weightings of James R Mcnab
James R Mcnab Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Mcnab has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 763 shares on May 5, 2017, which brought James R Mcnab around $155,603.
According to the SEC Form 4 filings, James R Mcnab has made a total of 0 transactions in Titan Pharmaceuticals Inc (TTNP) over the past 5 years. The most-recent trade in Titan Pharmaceuticals Inc is the acquisition of 56 shares on September 21, 2018, which cost James R Mcnab around $50,000.
Insider Trading History of James R Mcnab
- 1
James R Mcnab Trading Performance
GuruFocus tracks the stock performance after each of James R Mcnab's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James R Mcnab is 3.02%. GuruFocus also compares James R Mcnab's trading performance to market benchmark return within the same time period. The performance of stocks bought by James R Mcnab within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James R Mcnab's insider trading performs compared to the benchmark.
Performance of James R Mcnab
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.63 | | | | | |
| Relative Return to S&P 500(%) | 19.33 | | | | | |
James R Mcnab Ownership Network
Ownership Network List of James R Mcnab
Ownership Network Relation of James R Mcnab
James R Mcnab Owned Company Details
What does Titan Pharmaceuticals Inc do?
Who are the key executives at Titan Pharmaceuticals Inc?
James R Mcnab is the director of Titan Pharmaceuticals Inc. Other key executives at Titan Pharmaceuticals Inc include 10 percent owner Seow Gim Shen , 10 percent owner Sire Group Ltd. , and director & President and COO Katherine Beebe .
Titan Pharmaceuticals Inc (TTNP) Insider Trades Summary
Over the past 18 months, James R Mcnab made no insider transaction in Titan Pharmaceuticals Inc (TTNP). Other recent insider transactions involving Titan Pharmaceuticals Inc (TTNP) include a net sale of 7,495,936 shares made by David E. Lazar ,
In summary, during the past 3 months, insiders sold 0 shares of Titan Pharmaceuticals Inc (TTNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 374,797 shares of Titan Pharmaceuticals Inc (TTNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 374,797 shares.
Titan Pharmaceuticals Inc (TTNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Titan Pharmaceuticals Inc Insider Transactions
James R Mcnab Mailing Address
Above is the net worth, insider trading, and ownership report for James R Mcnab. You might contact James R Mcnab via mailing address: C/o Curis, Inc, 4 Maguire Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
